Fundz

Cancer Genetics, Inc reported raising $6 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATEMar 27, 2017

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Mar 27, 2017)

Round Type

Venture

Cherry HillBiotechnology

Quick answer

CANCER GENETICS, INC raised $6 Million in a funding round, dated March 27, 2017. CANCER GENETICS, INC is based in Cherry Hill, New Jersey, United States.

How much did CANCER GENETICS, INC raise?
CANCER GENETICS, INC raised $6 Million in a funding round on March 27, 2017.
What does CANCER GENETICS, INC do?
Cancer Diagnostic/Personalized Treatment
Where is CANCER GENETICS, INC based and how big is it?
CANCER GENETICS, INC is based in Cherry Hill, New Jersey, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CANCER GENETICS, INC that raised within 45 days of this round, from Fundz verified event records.

  • HEAT BIOLOGICS, INC. raised $500K (Seed) on May 11, 2017.
  • Hamilton Thorne raised $9.2M on May 10, 2017.
  • Fulcrum Therapeutics raised $5M on May 10, 2017.
  • ELIAS Animal Health, LLC raised $714K (Seed) on May 10, 2017.
  • Treace raised $5.9M on May 10, 2017.
  • Elite Pharmaceuticals raised $800K (Seed) on May 10, 2017.

Who to call at CANCER GENETICS, INC, and when

A new round usually means CANCER GENETICS, INC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CANCER GENETICS, INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CANCER GENETICS, INC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CANCER GENETICS, INC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CANCER GENETICS, INC

Location

201 ROUTE 17 NORTH

Cherry Hill, New Jersey, United States

About

Cancer Diagnostic/Personalized Treatment

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CANCER GENETICS, INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CANCER GENETICS, INC's next move

See what Strategic adds

CANCER GENETICS, INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.